Inhibiting pp2a upregulates b7-h3 expression and potentially increases the sensitivity of malignant meningiomas to immunotherapy by proteomics

HIGHLIGHTS

  • who: Hu B and collaborators from the Beijing Neurosurgical Institute, Capital Medical University, Beijing, China, Department of Neurosurgery, Beijing Tiantan Hospital have published the research work: Inhibiting PP2A Upregulates B7-H3 Expression and Potentially Increases the Sensitivity of Malignant Meningiomas to Immunotherapy by Proteomics, in the Journal: (JOURNAL)
  • what: The authors used proteomics to systematically identify immune-related proteins and their signal regulatory pathways in malignant meningiomas to provide new potential targets for the treatment of malignant meningiomas. In this study, a total of 55 fractions were collected, dried by speed vacuum centrifugation, and combined . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?